In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1771-1773

  Van Belkum, Alex ^a   Fahal, Ahmed H ^b   Van De Sande, Wendy W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EUMYCETOMA; FUNGAL STRAIN; FUNGUS; FUNGUS CULTURE; HUMAN; IN VITRO STUDY; LEPTOSPHAERIA SENEGALENSIS; MADURELLA GRISEA; MADURELLA MYCETOMATIS; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; PETRIELLIDIUM BOYDII; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ITRACONAZOLE; KETOCONAZOLE; MADURELLA; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; TRIAZOLES;

EID: 79953220785     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01045-10     Document Type: Article

References (15)

1. Ahmed, A. O., et al. 1999. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J. Clin. Microbiol. 37:3175-3178.
2. Ahmed, A. O., et al. 2004. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob. Agents Chemother. 48:2742-2746.
3. Badali, H., et al. 2010. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med. Mycol. 48:318-327.
4. Gilgado, F., C. Serena, J. Cano, J. Gene, and J. Guarro. 2006. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob. Agents Chemother. 50:4211-4213.
5. Jessup, C. J., N. S. Ryder, and M. A. Ghannoum. 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol. 38:155-159.
6. Kovarik, J. M., et al. 1995. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob. Agents Chemother. 39:2738-2741.
7. Lebeaux, D., et al. 2009. Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults. Antimicrob. Agents Chemother. 53:5224-5229.
8. N'Diaye, B., M. T. Dieng, A. Perez, M. Stockmeyer, and R. Bakshi. 2006. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int. J. Dermatol. 45:154-157.
9. Negroni, R., et al. 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev. Inst. Med. Trop. Sao Paulo 47:339-346.
10. Onyewu, C., J. R. Blankenship, M. Del Poeta, and J. Heitman. 2003. Ergosterol biosynthesis inhibitors become fungicidal when combined with cal-cineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47:956-964.
11. Sansone-Parsons, A., et al. 2007. Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers. Antimicrob. Agents Chemother. 51:495-502.
12. van de Sande, W. W., et al. 2005. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J. Clin. Microbiol. 43:4349-4356.
13. van de Sande, W. W., A. Luijendijk, A. O. Ahmed, I. A. Bakker-Woudenberg, and A. van Belkum. 2005. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob. Agents Chemother. 49:1364-1368.
14. van de Sande, W. W. J., A. H. Fahal, I. A. J. M. Bakker-Woudenberg, and A. van Belkum. 2010. Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrob. Agents Chemother. 54:2738-2740.
15. Yan, J., J. Deng, C. J. Zhou, B. Y. Zhong, and F. Hao. 2010. Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma. J. Clin. Microbiol. 48:251-257.